2022-01-27 06:46:25 GOOG Alphabet
Alphabet Class A
01/27/22 01/2706:46 01/27/2206:46 | Verily, GSK reach milestone in RA neuromodulation, first patient implantFive years ago, Verily, a subsidiary of Alphabet (GOOG;GOOGL), and GlaxoSmithKline (GSK) announced they were forming a new research and development-focused company, Galvani Bioelectronics. This new venture would be dedicated to treating chronic conditions, including Rheumatoid Arthritis, RA, through targeted neuromodulation therapies. Yesterday, the companies announced the successful implantation of the first-ever investigational treatment for RA through stimulation of the splenic nerve in a patient. The Galvani neurostimulator is designed to be implanted in a minimally invasive outpatient procedure. After implantation the patient and their care provider are then able to control, monitor, and charge the device as needed to ensure continued potential efficacy. In November 2021, a team of laparoscopic surgeons successfully completed the first implantation of a Galvani device in a patient. Over the last month, therapy was initiated as part of a small clinical study at the NHS Greater Glasgow and Clyde Health Board. At the same time, Galvani has also kicked off a larger U.S.-based study under approval from the FDA. This study will assess the safety and effectiveness of the Galvani platform in the RA patient population. Alphabet
Alphabet Class A
GlaxoSmithKline
|
|
---|
Downgrade
|
JBG Smith downgraded to Peer Perform from Outperform at Wolfe Research »
06:33 05/23/22 05/2306:33 05/23/2206:33
JBGS
JBG Smith Properties
Wolfe Research analyst… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
ImmunoGen's BLA for mirvetuximab soravtansine in ovarian cancer accepted by FDA »
06:32 05/23/22 05/2306:32 05/23/2206:32
IMGN
ImmunoGen
ImmunoGen announced that… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Johnson & Johnson assumed with an Outperform at SVB Leerink »
06:31 05/23/22 05/2306:31 05/23/2206:31
JNJ
Johnson & Johnson
SVB Leerink analyst David… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Walmart, Symbotic expand partnership »
06:31 05/23/22 05/2306:31 05/23/2206:31
WMT
Walmart
Symbotic, an A.I.-powered… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Baird a buyer into Petco Q1 results as shares offer good value »
06:31 05/23/22 05/2306:31 05/23/2206:31
WOOF
Petco
Baird analyst Peter… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Mirum Pharmaceuticals price target raised to $69 from $64 at H.C. Wainwright »
06:30 05/23/22 05/2306:30 05/23/2206:30
MIRM
Mirum Pharmaceuticals
H.C. Wainwright analyst… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Gilead initiated with a Market Perform at SVB Leerink »
06:29 05/23/22 05/2306:29 05/23/2206:29
GILD
Gilead
SVB Leerink analyst David… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
| UBS analyst Thomas… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Boxed price target lowered to $12 from $13 at Citi »
06:28 05/23/22 05/2306:28 05/23/2206:28
BOXD
Boxed
Citi analyst Ronald Josey… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Ouster initiated with an Overweight at Cantor Fitzgerald »
06:28 05/23/22 05/2306:28 05/23/2206:28
OUST
Ouster
Cantor Fitzgerald analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Applied Materials price target lowered to $160 from $175 at Citi »
06:27 05/23/22 05/2306:27 05/23/2206:27
AMAT
Applied Materials
Citi analyst Atif Malik… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
DTE Energy upgraded to Outperform from Neutral at Credit Suisse »
06:27 05/23/22 05/2306:27 05/23/2206:27
DTE
DTE Energy
Credit Suisse analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Alibaba price target lowered to $144 from $160 at Baird »
06:27 05/23/22 05/2306:27 05/23/2206:27
BABA
Alibaba
Baird analyst Colin… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Paramount price target lowered to $44 from $47 at Citi »
06:26 05/23/22 05/2306:26 05/23/2206:26
PARA
Paramount
Citi analyst Jason… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Horizon Therapeutics initiated with a Market Perform at SVB Leerink »
06:26 05/23/22 05/2306:26 05/23/2206:26
HZNP
Horizon Therapeutics
SVB Leerink analyst David… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Consolidated Edison upgraded to Neutral from Sell at Guggenheim »
06:26 05/23/22 05/2306:26 05/23/2206:26
ED
Consolidated Edison
Guggenheim analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Dell Technologies price target lowered to $65 from $70 at Citi »
06:25 05/23/22 05/2306:25 05/23/2206:25
DELL
Dell Technologies
Citi analyst Jim Suva… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Marvell price target lowered to $80 from $95 at UBS »
06:24 05/23/22 05/2306:24 05/23/2206:24
MRVL
Marvell
UBS analyst Timothy… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Foot Locker price target raised to $32 from $30 »
06:24 05/23/22 05/2306:24 05/23/2206:24
FL
Foot Locker
Baird analyst Jonathan… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
AbbVie initiated with an Underperform at SVB Leerink »
06:23 05/23/22 05/2306:23 05/23/2206:23
ABBV
AbbVie
SVB Leerink analyst David… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Stealth Biotherapeutics price target lowered to $1.50 from $4 at H.C. Wainwright »
06:22 05/23/22 05/2306:22 05/23/2206:22
MITO
Stealth Biotherapeutics
H.C. Wainwright analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Zymeworks price target lowered to $40 from $44 at H.C. Wainwright »
06:21 05/23/22 05/2306:21 05/23/2206:21
ZYME
Zymeworks
H.C. Wainwright analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Atara Biotherapeutics price target lowered to $29 from $31 at H.C. Wainwright »
06:20 05/23/22 05/2306:20 05/23/2206:20
ATRA
Atara Biotherapeutics
H.C. Wainwright analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Snowflake price target lowered to $180 from $260 at UBS »
06:20 05/23/22 05/2306:20 05/23/2206:20
SNOW
Snowflake
UBS analyst Karl… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Amgen initiated with a Market Perform at SVB Leerink »
06:20 05/23/22 05/2306:20 05/23/2206:20
AMGN
Amgen
SVB Leerink analyst David… Story temporarily locked. ShowHide Related Items >><<
|